Novo NordiskNovo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
About this email
Captured Announcement
Novo Nordisk announces a successful Dutch court injunction protecting patients from unapproved compounded semaglutide nasal spray.
Top-aligned brand logo followed by an extensive press release layout featuring bullet points, official statements, product background info, contact tables, and legal footers with minimal whitespace.
Color palette
Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.
